Target intelligence / Profile preview

NLR family pyrin domain containing 8 (NLRP8)

Target
NLRP8
Molecular classification
Receptor, NOD-like receptor (NLR), Pattern recognition receptor
01

Overview

NLR family pyrin domain containing 8 (NLRP8) is a member of the NOD-like receptor (NLR) protein family, characterized by an amino-terminal pyrin domain (PYD), a central NACHT domain (ATPase activity), and a carboxy-terminal leucine-rich repeat (LRR) domain[2]. The NLR family mediates pattern recognition as part of the innate immune system, sensing pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs)[2]. NLRP proteins, including NLRP8, are expressed in immune cells, where they may potentially contribute to inflammatory signaling[2]. While other NLRPs, such as NLRP3 and NLRP1, are known to form inflammasomes and play roles in inflammation, the specific molecular function and disease relevance of NLRP8 in humans remain uncharacterized and are not supported by current evidence. NLRP8 is not considered a validated therapeutic target, as there is no known implication in any disease, nor is there any documented drug targeting this molecule[2].

Other names
NACHT, LRR and PYD domains-containing protein 8NLRP8NALP8NOD16PAN4CLR19.2Nucleotide-binding oligomerization domain protein 16PYRIN and NACHT-containing protein 4
02

Biological functions

Innate immunityPattern recognitionInflammatory responseOther (no direct evidence for inflammasome formation comparable to NLRP3)
03

Disease associations

Other (no validated disease associations currently established for NLRP8 in humans)

Beyond the preview

Go deeper on NLR family pyrin domain containing 8 (NLRP8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NLR family pyrin domain containing 8 (NLRP8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call